Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.
McIntyre RS, Rodrigues NB, Lee Y, Lipsitz O, Subramaniapillai M, Gill H, Nasri F, Majeed A, Lui LMW, Senyk O, Phan L, Carvalho IP, Siegel A, Mansur RB, Brietzke E, Kratiuk K, Arekapudi AK, Abrishami A, Chau EH, Szpejda W, Rosenblat JD. McIntyre RS, et al. Among authors: lipsitz o. J Affect Disord. 2020 Sep 1;274:903-910. doi: 10.1016/j.jad.2020.05.088. Epub 2020 May 26. J Affect Disord. 2020. PMID: 32664031
Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
Rodrigues NB, McIntyre RS, Lipsitz O, Cha DS, Lee Y, Gill H, Majeed A, Phan L, Nasri F, Ho R, Lin K, Subramaniapillai M, Kratiuk K, Mansur RB, Rosenblat JD. Rodrigues NB, et al. Among authors: lipsitz o. J Affect Disord. 2020 Nov 1;276:570-575. doi: 10.1016/j.jad.2020.07.083. Epub 2020 Jul 20. J Affect Disord. 2020. PMID: 32871688
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.
McIntyre RS, Carvalho IP, Lui LMW, Majeed A, Masand PS, Gill H, Rodrigues NB, Lipsitz O, Coles AC, Lee Y, Tamura JK, Iacobucci M, Phan L, Nasri F, Singhal N, Wong ER, Subramaniapillai M, Mansur R, Ho R, Lam RW, Rosenblat JD. McIntyre RS, et al. Among authors: lipsitz o. J Affect Disord. 2020 Nov 1;276:576-584. doi: 10.1016/j.jad.2020.06.050. Epub 2020 Jul 21. J Affect Disord. 2020. PMID: 32871689 Review.
Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder.
Rashidian H, Subramaniapillai M, Park C, Lipsitz O, Zuckerman H, Teopiz K, Cao B, Lee Y, Gill H, Ho R, Lin K, Rodrigues NB, Iacobucci M, Rosenblat JD, McIntyre RS, Mansur RB. Rashidian H, et al. Among authors: lipsitz o. J Affect Disord. 2021 Mar 1;282:448-453. doi: 10.1016/j.jad.2020.12.074. Epub 2020 Dec 24. J Affect Disord. 2021. PMID: 33422821
Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment.
McIntyre RS, Rodrigues NB, Lipsitz O, Lee Y, Cha DS, Gill H, Lui LMW, Subramaniapillai M, Kratiuk K, Ho R, Mansur RB, Rosenblat JD. McIntyre RS, et al. Among authors: lipsitz o. J Affect Disord. 2021 Jun 1;288:210-216. doi: 10.1016/j.jad.2021.03.053. Epub 2021 Mar 26. J Affect Disord. 2021. PMID: 33965843
Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries.
Lee Y, Lui LMW, Chen-Li D, Liao Y, Mansur RB, Brietzke E, Rosenblat JD, Ho R, Rodrigues NB, Lipsitz O, Nasri F, Cao B, Subramaniapillai M, Gill H, Lu C, McIntyre RS. Lee Y, et al. Among authors: lipsitz o. J Affect Disord. 2021 Jul 1;290:364-377. doi: 10.1016/j.jad.2021.04.050. Epub 2021 May 27. J Affect Disord. 2021. PMID: 34052584 Free PMC article. Review.
50 results